Home › Funds › Avoro Capital Advisors LLC › OCUL

Avoro Capital Advisors LLC position in OCUL

OCULAR THERAPEUTIX INC · Health Care

Avoro Capital Advisors LLC reported holding 12,380,300 shares of OCUL (OCULAR THERAPEUTIX INC) in its Q3 2026 13F filing — a position valued at US$95.0M, representing 0.98% of its reported portfolio and ranking #17 among its reported holdings. Avoro Capital Advisors LLC has disclosed OCUL holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)12.38M sh
Reported value held$94.96M
Portfolio Weight0.98%
First reportedQ1 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Avoro Capital Advisors LLC's OCUL position evolved

Avoro Capital Advisors LLC first disclosed a stake in OCUL in Q1 2024 at 7,148,936 shares (US$65.1M). The position peaked in Q4 2025 at 10,777,777 shares, worth US$130.8M. Across 11 filings, Avoro Capital Advisors LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 12,380,300 shares valued at US$95.0M — a reduction of -159,700 shares quarter over quarter.. Notable position changes include a 39% increase in Q3 2025 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 7.15M $65.06M New
Q2 2024 8.06M $55.13M Add
Q3 2024 8.06M $70.12M Hold
Q4 2024 8.06M $68.83M Hold
Q1 2025 8.06M $59.08M Hold
Q2 2025 7.40M $68.67M Reduce
Q3 2025 10.25M $119.82M Add
Q4 2025 10.78M $130.84M Add
Q1 2026 12.31M $104.31M Add
Q2 2026 12.54M $123.14M Add
Q3 2026 12.38M $94.96M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OCUL and 13F data

OCUL (OCULAR THERAPEUTIX INC) is a Health Care company. 33 other funds we track also report a position in OCUL — the largest reported positions include Deep Track Capital, LP (US$168.3M), Venrock Adviser, LLC (US$101.6M), SUMMER ROAD LLC (US$95.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OCUL

All OCUL fund holders →

FAQ

How long has Avoro Capital Advisors LLC held OCUL?

Avoro Capital Advisors LLC has disclosed OCUL holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Avoro Capital Advisors LLC's current position in OCUL?

As of Q3 2026, Avoro Capital Advisors LLC holds 12.38M shares of OCUL (OCULAR THERAPEUTIX INC), valued at $94.96M, representing 0.98% of its reported portfolio and ranking #17.

Has Avoro Capital Advisors LLC been buying or selling OCUL?

In the latest 13F filing (Q3 2026), Avoro Capital Advisors LLC reduced its position in OCUL. The position peaked in Q4 2025 at 10.78M shares.

Which other funds hold OCUL?

Other major institutional holders of OCUL include Deep Track Capital, LP, Venrock Adviser, LLC, SUMMER ROAD LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.